2Brown B G, Zhao X Q. Importace ofendothelial function in mediating thebenefits of lipidlowering therapy[J]. Am J Cardiol, 1998, 82(10B):49T-52T. 被引量：1
3Grethe S. Tell George Howard, William M, et al. Risk factors for site specific extracranial carotid artery plaque distribution as measured by B-mode ultraso-und[J]. J Clin Epidemiol, 1989, 42:551-559. 被引量：1
4Prisant L M, Zemel P C, Nichols F T, et al. Carotid plaque associations among hypertensive patients[J]. Arch Intern Med, 1993, 153(4):501-506. 被引量：1
5Corti R, Fayad Z A, Fuster V, et al. Effects of lipidlowering by simvastatin on human atherosclerotic lesions [J]. Circulation, 2001, 104(3):249-252. 被引量：1
6Knapp A C, Huang J, Starling G, et al. Inhibitors of HMGCOA reductase sensitize human smooth muscle cells to Fasligand and cytokineinduced cell death [J]. Atherosclerosis, 2000, 152:217- 227. 被引量：1
7Gordon D, Rifkind B M. Currint concepts:high density lipoproteinsthe clinical implications of recent studies[J]. N Engl J Med, 1989, 321:1311-1315. 被引量：1
8Henderson D C. Schizophrenia and comorbid metabolic disor- ders[J]. J Clin Psychiatry,2005,66 (6): 11-20. 被引量：1
9Holt AIG, Peveler R C. Association between antipsychiotic drugs and diabetes[J]. Diabetes Qbes Metab,2006, 8: 125-135. 被引量：1
10Kohen D. Diabetes mellitus and schizophrenia: historical per- spective[J]. Br J Psychiatry ,2004,184 (Suppl 47): S64-66. 被引量：1
